We further show that although pharmacological inhibition of ATX activity per os is not efficient to prevent tumour growth because of a positive feedback regulation that induces the expression of ATX in tumour cells, the combined opposite targeting of p110δ and RhoA bypasses this positive feedback expression of ATX. This evidence concerns the gene PIK3CD and neoplasm.